Abstract
Parkinson’s disease (PD) is a common neurodegenerative disease characterized by neuronal loss in the substantia nigra. The p75 neurotrophin receptor (p75NTR, encoded by NGFR) was found to play an important role in the selective neuronal death of dopamine neurons in the substantia nigra, as well as the pathogenesis and development of PD. To assess the association between NGFR gene polymorphism and the susceptibility of PD, this case-control study consisting of 414 PD patients and 623 age- and sex-matched controls in a Chinese Han cohort was conducted. Twelve tag-single nucleotide polymorphisms (tag-SNPs) were selected from the NGFR gene through the construction of linkage disequilibrium blocks. One tag-SNP from the ADAM17 gene was also selected owing to its function of encoding tumor necrosis factor α-converting enzyme, which is responsible for the shedding of the extracellular domain of p75NTR. A multiplex polymerase chain reaction-ligase detection reaction (PCR-LDR) method was applied for genotyping. The associations between tag-SNPs and the risk of PD with the adjustment for age and sex were analyzed by unconditional logistic regression, and five genetic models including codominant, dominant, recessive, over-dominant, and additive models were applied. The results showed that among the 13 tag-SNPs, rs741073 was associated with a reduced risk of PD in the codominant (OR = 0.71, 95% CI = 0.54–0.93, P = 0.037), dominant (OR = 0.76, 95% CI = 0.58–0.98, P = 0.033), and over-dominant models (OR = 0.71, 95% CI = 0.54–0.92, P = 0.010), and rs1804011 was also associated with a reduced risk of PD in the codominant (OR = 0.69, 95% CI = 0.50–0.95, P = 0.049), dominant (OR = 0.69, 95% CI = 0.50–0.93, P = 0.014), over-dominant (OR = 0.70, 95% CI = 0.51–0.96, P = 0.025), and additive models (OR = 0.72, 95% CI = 0.54–0.94, P = 0.016). However, these associations did not retain after Bonferroni correction. Conclusively, our study failed to reveal the association between the selected tag-SNPs within NGFR, ADAM17, and the susceptibility of PD. The role of p75NTR and its gene polymorphisms in the pathogenesis of PD needs to be further studied.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abou-Sleiman PM, Muqit MM, Wood NW (2006) Expanding insights of mitochondrial dysfunction in Parkinson’s disease. Nat Rev Neurosci 7:207–219. https://doi.org/10.1038/nrn1868
Alavian KN, Sgado P, Alberi L, Subramaniam S, Simon HH (2009) Elevated P75NTR expression causes death of engrailed-deficient midbrain dopaminergic neurons by Erk1/2 suppression. Neural Dev 4:11. https://doi.org/10.1186/1749-8104-4-11
Al-Shawi R, Hafner A, Chun S, Raza S, Crutcher K et al (2007) ProNGF, sortilin, and age-related neurodegeneration. Ann N Y Acad Sci 1119:208–215. https://doi.org/10.1196/annals.1404.024
Barrett GL (2000) The p75 neurotrophin receptor and neuronal apoptosis. Prog Neurobiol 61:205–229
Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265. https://doi.org/10.1093/bioinformatics/bth457
Bian GL, Wei LC, Shi M, Wang YQ, Cao R, Chen LW (2007) Fluoro-Jade C can specifically stain the degenerative neurons in the substantia nigra of the 1-methyl-4-phenyl-1,2,3,6-tetrahydro pyridine-treated C57BL/6 mice. Brain Res 1150:55–61. https://doi.org/10.1016/j.brainres.2007.02.078
Chen LW, Wang YQ, Bian GL, Wei LC, Yung KL (2008a) Neurokinin-3 peptide instead of neurokinin-1 synergistically exacerbates kainic acid-inducing degeneration of neurons in the substantia nigra of mice. J Neurochem 105:203–216. https://doi.org/10.1111/j.1471-4159.2007.05132.x
Chen LW, Yung KK, Chan YS, Shum DK, Bolam JP (2008b) The proNGF-p75NTR-sortilin signalling complex as new target for the therapeutic treatment of Parkinson’s disease. CNS Neurol Disord Drug Targets 7:512–523
Cheng HC, Sun Y, Lai LC, Chen SY, Lee WC, Chen JH, Chen TF, Chen HH, Wen LL, Yip PK, Chu YM, Chen WJ, Chen YC (2012) Genetic polymorphisms of nerve growth factor receptor (NGFR) and the risk of Alzheimer’s disease. J Negat Results Biomed 11:5. https://doi.org/10.1186/1477-5751-11-5
Compta Y, Parkkinen L, O'Sullivan SS, Vandrovcova J, Holton JL, Collins C, Lashley T, Kallis C, Williams DR, de Silva R, Lees AJ, Revesz T (2011) Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important? Brain J Neurol 134:1493–1505. https://doi.org/10.1093/brain/awr031
Cozza A, Melissari E, Iacopetti P, Mariotti V, Tedde A, Nacmias B, Conte A, Sorbi S, Pellegrini S (2008) SNPs in neurotrophin system genes and Alzheimer’s disease in an Italian population. J Alzheimers Dis: JAD 15:61–70
Esler WP, Wolfe MS (2001) A portrait of Alzheimer secretases--new features and familiar faces. Science 293:1449–1454. https://doi.org/10.1126/science.1064638
Fernandez-Espejo E (2004) Pathogenesis of Parkinson’s disease: prospects of neuroprotective and restorative therapies. Mol Neurobiol 29:15–30. https://doi.org/10.1385/MN:29:1:15
Fujii T, Yamamoto N, Hori H, Hattori K, Sasayama D, Teraishi T, Hashikura M, Tatsumi M, Okamoto N, Higuchi T, Kunugi H (2011) Support for association between the Ser205Leu polymorphism of p75(NTR) and major depressive disorder. J Hum Genet 56:806–809. https://doi.org/10.1038/jhg.2011.107
Gau YT, Liou YJ, Yu YW, Chen TJ, Lin MW et al (2008) Evidence for association between genetic variants of p75 neurotrophin receptor (p75NTR) gene and antidepressant treatment response in Chinese major depressive disorder. Am J Med Genet Part B, Neuropsychiatr Genet:Off Publ Int Soc Psychiatr Genet 147B:594–599. https://doi.org/10.1002/ajmg.b.30646
Gibson TM, Wang SS, Cerhan JR, Maurer MJ, Hartge P, Habermann TM, Davis S, Cozen W, Lynch CF, Severson RK, Rothman N, Chanock SJ, Morton LM (2012) Inherited genetic variation and overall survival following follicular lymphoma. Am J Hematol 87:724–726. https://doi.org/10.1002/ajh.23184
Goris A, Williams-Gray CH, Clark GR, Foltynie T, Lewis SJ et al (2007) Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson’s disease. Ann Neurol 62:145–153. https://doi.org/10.1002/ana.21192
Hamza TH, Zabetian CP, Tenesa A, Laederach A, Montimurro J, Yearout D, Kay DM, Doheny KF, Paschall J, Pugh E, Kusel VI, Collura R, Roberts J, Griffith A, Samii A, Scott WK, Nutt J, Factor SA, Payami H (2010) Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson’s disease. Nat Genet 42:781–785. https://doi.org/10.1038/ng.642
Junyent M, Parnell LD, Lai CQ, Arnett DK, Tsai MY et al (2010) ADAM17_i33708A>G polymorphism interacts with dietary n-6 polyunsaturated fatty acids to modulate obesity risk in the Genetics of Lipid Lowering Drugs and Diet Network study nutrition, metabolism, and cardiovascular diseases. NMCD 20:698–705
Kalaitzakis ME, Graeber MB, Gentleman SM, Pearce RK (2008) Striatal beta-amyloid deposition in Parkinson disease with dementia. J Neuropathol Exp Neurol 67:155–161. https://doi.org/10.1097/NEN.0b013e31816362aa
Kunugi H, Hashimoto R, Yoshida M, Tatsumi M, Kamijima K (2004) A missense polymorphism (S205L) of the low-affinity neurotrophin receptor p75NTR gene is associated with depressive disorder and attempted suicide. Am J Med Genet Part B, Neuropsychiatric Genet : Off Publ Int Soc Psychiatr Genet 129B:44–46. https://doi.org/10.1002/ajmg.b.30062
Laws SM, Friedrich P, Diehl-Schmid J, Muller J, Eisele T et al (2007) Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer’s disease. Mol Psychiatry 12:510–517. https://doi.org/10.1038/sj.mp.4001935
Lippa CF, Pulaski-Salo D, Dickson DW, Smith TW (1997) Alzheimer’s disease, Lewy body disease and aging: a comparative study of the perforant pathway. J Neurol Sci 147:161–166
Lorraine VK, Anthony EL (2015) Parkinson’s disease. Lancet 386:896–912. https://doi.org/10.1016/S0140-6736(14)61393-3
Luo Y (1999) Chinese diagnostic criteria of Parkinson’s disease. Chin J Prac Intern Med 19:325–328
Maraganore DM, de Andrade M, Elbaz A, Farrer MJ, Ioannidis JP et al (2006) Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. Jama 296:661–670. https://doi.org/10.1001/jama.296.6.661
Nalls MA, Plagnol V, Hernandez DG, Sharma M, Sheerin UM et al (2011) Imputation of sequence variants for identification of genetic risks for Parkinson’s disease: a meta-analysis of genome-wide association studies. Lancet 377:641–649. https://doi.org/10.1016/s0140-6736(10)62345-8
Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG et al (2014) Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat Genet 46:989–993. https://doi.org/10.1038/ng.3043
Olanow CW, Tatton WG (1999) Etiology and pathogenesis of Parkinson’s disease. Annu Rev Neurosci 22:123–144. https://doi.org/10.1146/annurev.neuro.22.1.123
Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, Niinistö L, Halonen P, Kontula K (1995) Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. N Engl J Med 333:1242–1247. https://doi.org/10.1056/NEJM199511093331902
Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, Kubo M, Kawaguchi T, Tsunoda T, Watanabe M, Takeda A, Tomiyama H, Nakashima K, Hasegawa K, Obata F, Yoshikawa T, Kawakami H, Sakoda S, Yamamoto M, Hattori N, Murata M, Nakamura Y, Toda T (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson’s disease. Nat Genet 41:1303–1307. https://doi.org/10.1038/ng.485
Shen LL, Manucat-Tan NB, Gao SH, Li WW, Zeng F et al (2018) The ProNGF/p75NTR pathway induces tau pathology and is a therapeutic target for FTLD-tau. Mol Psychiatry 23:1813–1824. https://doi.org/10.1038/s41380-018-0071-z
Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, Bar-Shira A, Berg D, Bras J, Brice A, Chen CM, Clark LN, Condroyer C, de Marco EV, Dürr A, Eblan MJ, Fahn S, Farrer MJ, Fung HC, Gan-Or Z, Gasser T, Gershoni-Baruch R, Giladi N, Griffith A, Gurevich T, Januario C, Kropp P, Lang AE, Lee-Chen GJ, Lesage S, Marder K, Mata IF, Mirelman A, Mitsui J, Mizuta I, Nicoletti G, Oliveira C, Ottman R, Orr-Urtreger A, Pereira LV, Quattrone A, Rogaeva E, Rolfs A, Rosenbaum H, Rozenberg R, Samii A, Samaddar T, Schulte C, Sharma M, Singleton A, Spitz M, Tan EK, Tayebi N, Toda T, Troiano AR, Tsuji S, Wittstock M, Wolfsberg TG, Wu YR, Zabetian CP, Zhao Y, Ziegler SG (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 361:1651–1661. https://doi.org/10.1056/NEJMoa0901281
Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR et al (2009) Genome-wide association study reveals genetic risk underlying Parkinson’s disease. Nat Genet 41:1308–1312. https://doi.org/10.1038/ng.487
Sole X, Guino E, Valls J, Iniesta R, Moreno V (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics 22:1928–1929. https://doi.org/10.1093/bioinformatics/btl268
Szczepankiewicz A, Sobkowiak P, Rachel M, Breborowicz A, Schoneich N et al (2012) Multilocus analysis of candidate genes involved in neurogenic inflammation in pediatric asthma and related phenotypes: a case-control study. J Asthma 49:329–335. https://doi.org/10.3109/02770903.2012.669442
Wang YQ, Bian GL, Bai Y, Cao R, Chen LW (2008) Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats. Neurochem Int 53:56–62. https://doi.org/10.1016/j.neuint.2008.06.007
Wang M, Li Y, Lu Y, Zuo X, Wang F, Zhang Z, Jia J (2010) The relationship between ADAM17 promoter polymorphisms and sporadic Alzheimer’s disease in a Northern Chinese Han population. J Clin Neurosci: Off J Neurosurg Soc Australasia 17:1276–1279. https://doi.org/10.1016/j.jocn.2010.01.008
Weskamp G, Schlondorff J, Lum L, Becherer JD, Kim TW et al (2004) Evidence for a critical role of the tumor necrosis factor alpha convertase (TACE) in ectodomain shedding of the p75 neurotrophin receptor (p75NTR). J Biol Chem 279:4241–4249. https://doi.org/10.1074/jbc.M307974200
Williams-Gray CH, Goris A, Saiki M, Foltynie T, Compston DA et al (2009) Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson’s disease. J Neurol 256:493–498. https://doi.org/10.1007/s00415-009-0119-8
Xia Y, Chen BY, Sun XL, Duan L, Gao GD, Wang JJ, Yung K, Chen LW (2013) Presence of proNGF-sortilin signaling complex in nigral dopamine neurons and its variation in relation to aging, lactacystin and 6-OHDA insults. Int J Mol Sci 14:14085–14104. https://doi.org/10.3390/ijms140714085
Xu Z, Taylor JA (2009) SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res 37:W600–W605
Yao XQ, Jiao SS, Saadipour K, Zeng F, Wang QH, Zhu C, Shen LL, Zeng GH, Liang CR, Wang J, Liu YH, Hou HY, Xu X, Su YP, Fan XT, Xiao HL, Lue LF, Zeng YQ, Giunta B, Zhong JH, Walker DG, Zhou HD, Tan J, Zhou XF, Wang YJ (2015) p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer’s disease. Mol Psychiatry 20:1301–1310. https://doi.org/10.1038/mp.2015.49
Yuan HY, Chiou JJ, Tseng WH, Liu CH, Liu CK, Lin YJ, Wang HH, Yao A, Chen YT, Hsu CN (2006) FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 34:W635–W641
Zeng F, Lu JJ, Zhou XF, Wang YJ (2011) Roles of p75NTR in the pathogenesis of Alzheimer’s disease: a novel therapeutic target. Biochem Pharmacol 82:1500–1509. https://doi.org/10.1016/j.bcp.2011.06.040
Zeng F, Zou HQ, Zhou HD, Li J, Wang L, Cao HY, Yi X, Wang X, Liang CR, Wang YR, Zhang AQ, Tan XL, Peng KR, Zhang LL, Gao CY, Xu ZQ, Wen AQ, Lian Y, Zhou XF, Wang YJ (2013) The relationship between single nucleotide polymorphisms of the NTRK2 gene and sporadic Alzheimer’s disease in the Chinese Han population. Neurosci Lett 550:55–59. https://doi.org/10.1016/j.neulet.2013.06.061
Funding
This study was supported by the National Natural Science Foundation of China (Grant no. 81870860 and 81571239) and the Ministry of Science and Technology of China (Grant no.2016YFC1306401).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Supplementary Table 1.
(DOCX 19 kb)
Rights and permissions
About this article
Cite this article
Li, WW., Shen, YY., Chen, DW. et al. Genetic Association Between NGFR, ADAM17 Gene Polymorphism, and Parkinson’s Disease in the Chinese Han Population. Neurotox Res 36, 463–471 (2019). https://doi.org/10.1007/s12640-019-00031-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12640-019-00031-z